Ascentage Pharma Group International (AAPG)
NASDAQ: AAPG · Real-Time Price · USD
41.15
+0.95 (2.36%)
Aug 13, 2025, 4:00 PM - Market closed
AAPG Employees
Ascentage Pharma Group International had 567 employees as of December 31, 2024. The number of employees decreased by 16 or -2.74% compared to the previous year.
Employees
567
Change (1Y)
-16
Growth (1Y)
-2.74%
Revenue / Employee
$236,953
Profits / Employee
-$97,964
Market Cap
3.84B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 567 | -16 | -2.74% |
Dec 31, 2023 | 583 | 3 | 0.52% |
Dec 31, 2022 | 580 | -33 | -5.38% |
Dec 31, 2021 | 613 | 180 | 41.57% |
Dec 31, 2020 | 433 | 23 | 5.61% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AAPG News
- 6 days ago - Ascentage Pharma to Report 2025 Six Month Interim Results and Provide Corporate Update on August 20, 2025 - GlobeNewsWire
- 12 days ago - Ascentage Pharma to Participate in Evercore China Biotech Summit - GlobeNewsWire
- 4 weeks ago - Ascentage Pharma Announces Closing of Placement Shares in Top-Up Placement - GlobeNewsWire
- 4 weeks ago - Ascentage Pharma Announces Pricing of Top-Up Placement - GlobeNewsWire
- 4 weeks ago - Ascentage Pharma Announces Proposed Top-Up Placement - GlobeNewsWire
- 4 weeks ago - Ascentage Pharma Announces Its Novel Bcl-2 Inhibitor Lisaftoclax Approved by China NMPA, Ushering in a New Era for the Treatment of CLL/SLL - GlobeNewsWire
- 5 weeks ago - Ascentage Pharma Appoints Dr. Veet Misra as Chief Financial Officer and Eric Huang as Senior Vice President of Global Corporate Development and Finance - GlobeNewsWire
- 2 months ago - EHA 2025 | Multiple Studies Report Encouraging Data of Olverembatinib in Ph+ ALL - GlobeNewsWire